DCT
1:20-cv-01589
Astellas Pharma Inc v. Sandoz Inc
General
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (01/26/21)
Patent Owner
NPE (W)
PACER1:20-cv-01589
Nature of Suit835 ANDA
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
-- | 51% |
Plaintiff
Party
Name | Ratings |
|---|---|
L3A | |
L3A | |
L3A |
Attorney
Name | Ratings |
|---|---|
L5B | |
L5A | |
L5E | |
L5E | |
L3B | |
L3D | |
L3E | |
L3-- -- | |
L2-- -- | |
L2-- -- | |
L1-- -- | |
---- -- | |
---- -- | |
---- -- | |
---- -- | |
L5C | |
L5D | |
L4E | |
L3B | |
L3B | |
L3D | |
L2D | |
---- -- | |
---- -- | |
L4A | |
L5A | |
L3B | |
L3C | |
L3B | |
L5B | |
L5B | |
L4B | |
L4D | |
L3D | |
L3-- -- | |
Attorney at LawLocal | ---- -- |
---- -- |
Defendant
Party
Name | Ratings |
|---|---|
L5E | |
L4E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L4E | |
L4E | |
L4E | |
L4E | |
L4E | |
L2C | |
L2D | |
L2D | |
L2E | |
L2E | |
L2E | |
L1B | |
L1B | |
L1E | |
---- -- |
Attorney
Name | Ratings |
|---|---|
L5A | |
L3C | |
L3C | |
L3C | |
L5B | |
L5E | |
L5E | |
L4A | |
L4D | |
L2D | |
L5B | |
L5A | |
L5B | |
L5D | |
L5D | |
L5E | |
L5E | |
L4C | |
L4D | |
L3C | |
L2D | |
---- -- | |
---- -- | |
L5B | |
---- -- | |
---- -- | |
---- -- | |
Shaw Keller LLPLocal | L4D |
L4E | |
L3B | |
L4D | |
L4B | |
L1E | |
L1E | |
Morris James LLPLocal | L4E |
L4E | |
L4E | |
L5E | |
L4E | |
L3B | |
L5B | |
L5D | |
L4B | |
L4B | |
L4B | |
L2C | |
L2D | |
L1C | |
---- -- | |
---- -- | |
L3C | |
L5B | |
L5C | |
L5D | |
L4B | |
L4C | |
L4C | |
L3E | |
---- -- | |
---- -- | |
L3D | |
L4E | |
L2C | |
L1B | |
L3E | |
L4E | |
L4E | |
L3E | |
L3E | |
L3E | |
L5D | |
L5E | |
L5E | |
L3D | |
L2D | |
L1C | |
L1C | |
L1C | |
Abrams & Bayliss LLPLocal | L2D |
L2D | |
---- -- | |
L2E | |
L5E | |
L1E | |
---- -- | |
Attorney at LawLocal | ---- -- |
---- -- | |
---- -- | |
---- -- |